CORD - Centre de l'Oxygène, Recherche et Développement - ULiège
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
GACH, Olivier ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
BROGNEAUX, Cédric ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
Franck, Thierry ; Université de Liège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
Serteyn, Didier ; Université de Liège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Anesthésiologie gén. et pathologie chirurg. des grds animaux
Legrand, Victor ; Université de Liège > Relations académiques et scientifiques (Médecine)
Pierard, Luc ; Université de Liège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Magne, Julien; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
Language :
English
Title :
Active and total myeloperoxidase in coronary artery disease and relation to clinical instability.
Publication date :
2015
Journal title :
Acta Cardiologica
ISSN :
0001-5385
eISSN :
1784-973X
Publisher :
Association Royale des Sociétés Scientifiques Medicales Belges/Koninklijke Vereniging van de Belgische Medische Wetenschappelijke Genootschappen, Bruxelles, Belgium
Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286: 2136-42.
Gach O, Biemar C, Nys M, Deby-Dupont G, Chapelle JP, Deby C, Lamy M, Pierard LA, Legrand V. Early release of neutrophil markers of activation after direct stenting in patients with unstable angina. Coron Artery Dis 2005; 16: 59-65.
Gach O, Nys M, Deby-Dupont G, Chapelle JP, Lamy M, Pierard LA, Legrand V. Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients. Int J Cardiol 2006; 112: 59-65.
Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003; 349: 1595-604.
Pincemail J, Deby-Dupont G, Deby C, Thirion A, Torpier G, Faymonville ME, Damas P, Tomassini M, Lamy M, Franchimont P. Fast double antibody radioimmunoassay of human granulocyte myeloperoxidase and its application to plasma. J Immunol Methods 1991; 137: 181-91.
Malle E, Furtmuller PG, Sattler W, Obinger C. Myeloperoxidase: a target for new drug development? Br J Pharmacol 2007; 152: 838-54.
De la Harpe J, Nathan CF. A semi-automated micro-assay for H2O2 release by human blood monocytes and mouse peritoneal macrophages. J Immunol Methods 1985; 78: 323-36.
Franck T, Kohnen S, Deby-Dupont G, Grulke S, Deby C, Serteyn D. A specific method for measurement of equine active myeloperoxidase in biological samples and in in vitro tests. J Vet Diagn Invest 2006; 18: 326-34.
Franck T, Kohnen S, Boudjeltia KZ, Van Antwerpen P, Bosseloir A, Niesten A, Gach O, Nys M, Deby-Dupont G, Serteyn D. A new easy method for specific measurement of active myeloperoxidase in human biological fluids and tissue extracts. Talanta 2009; 80: 723-9.
Davies MJ, Hawkins CL, Pattison DI, Rees M.D.. Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid Redox Signal 2008; 10: 1199-234.
Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, Brummer J, Rudolph V, Munzel T, Heitzer T, Meinertz T, Baldus S. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A 2005; 102: 431-6.
Zhang R, Brennan ML, Shen Z, MacPherson JC, Schmitt D, Molenda CE, Hazen SL. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 2002; 277: 46116-22.
Gach O, Magne J, Franck T, Derochette S, Deby G, Serteyn D, Defraigne JO, Lancellotti P, Legrand V, Pierard LA. Clinical significance of active myeloperoxidase in carotid atherosclerotic plaques. Int J Cardiol 2011; 152: 149-51.
Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007; 50: 159-65.
Cavusoglu E, Ruwende C, Eng C, Chopra V, Yanamadala S, Clark LT, Pinsky DJ, Marmur JD. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 2007; 99: 1364-8.
Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, Winterbourn CC. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007; 49: 1993-2000.
